Literature DB >> 15625413

Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury.

Sari Mäkimattila1, Kirsi Malmberg-Cèder, Anna-Maija Häkkinen, Kim Vuori, Oili Salonen, Paula Summanen, Hannele Yki-Järvinen, Markku Kaste, Sami Heikkinen, Nina Lundbom, Risto O Roine.   

Abstract

Microangiopathic end-organ injury is common in type 1 diabetes. However, the pathophysiology of diabetic encephalopathy is poorly understood. The authors studied 10 normotensive patients with type 1 diabetes with retinopathy, autonomic neuropathy, but without nephropathy, and 10 healthy subjects. Proton magnetic resonance spectroscopy was performed at 1.5 T in the frontal cortex, thalamus, and posterior frontal white matter. There was no change in N-acetyl-containing compounds (NA), but choline-containing compounds (Cho) were increased in the white matter and in the thalamus; myo-inositol was increased in the white matter, glucose excess was found in all brain, and water intensity was increased in the cortical voxel in the patients. Calculated lifetime glycemic exposure correlated inversely with Cho and NA in white matter and with Cho in thalamus. Concentrations of soluble intercellular adhesion molecules and vascular cell adhesion molecules were increased in the patients. In conclusion, in patients with type 1 diabetes, the increase in adhesion molecules and an association between altered brain metabolites and glycemic exposure suggest the presence of a vascularly mediated, progressive metabolic disturbance in the brain.

Entities:  

Mesh:

Year:  2004        PMID: 15625413     DOI: 10.1097/01.WCB.0000143700.15489.B2

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  38 in total

Review 1.  Autophagy in the brains of young patients with poorly controlled T1DM and fatal diabetic ketoacidosis.

Authors:  William H Hoffman; John J Shacka; Anuska V Andjelkovic
Journal:  Exp Mol Pathol       Date:  2011-11-06       Impact factor: 3.362

Review 2.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

3.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

4.  Cerebellar glucose during fasting and acute hyperglycemia in nondiabetic men and in men with type 1 diabetes.

Authors:  Outi Heikkilä; Sari Mäkimattila; Marjut Timonen; Per-Henrik Groop; Sami Heikkinen; Nina Lundbom
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

Review 5.  Diabetes and brain damage: more (or less) than meets the eye?

Authors:  Christopher M Ryan
Journal:  Diabetologia       Date:  2006-10       Impact factor: 10.122

6.  Type-2 diabetes mellitus reduces cortical thickness and decreases oxidative metabolism in sensorimotor regions after stroke.

Authors:  Jennifer K Ferris; Sue Peters; Katlyn E Brown; Katherine Tourigny; Lara A Boyd
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-12       Impact factor: 6.200

7.  Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism.

Authors:  Outi Heikkilä; Nina Lundbom; Marjut Timonen; Per-Henrik Groop; Sami Heikkinen; Sari Mäkimattila
Journal:  Metab Brain Dis       Date:  2008-07-22       Impact factor: 3.584

8.  Region-specific cerebral metabolic alterations in streptozotocin-induced type 1 diabetic rats: an in vivo proton magnetic resonance spectroscopy study.

Authors:  Hui Zhang; Mingming Huang; Lifeng Gao; Hao Lei
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-03       Impact factor: 6.200

9.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

Review 10.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.